Augtyro

Active Ingredient(s): Repotrectinib
FDA Approved: * November 15, 2023
Pharm Company: * BRISTOL-MYERS SQUIBB CO
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Augtyro 40 mg Oral Capsule
NDC: 0003-4040
Labeler:
E.r. Squibb & Sons, L.L.C.